Published date: 
Thursday, 30 June, 2016
Author(s): 
Olotu A, Fegan G, Wambua J, Nyangweso G, Leach A, et al.
Body: 

RTS,S/AS01 is a malaria vaccine candidate that has undergone phase 3 evaluation across several sites in Africa that have varying intensities of malaria transmission.